Skull Base 2009; 19(2): 117-125
DOI: 10.1055/s-0028-1096209
ORIGINAL ARTICLE

© Thieme Medical Publishers

Imaging Findings of Rhinocerebral Mucormycosis

Diego A. Herrera1 , Arthur B. Dublin2 , Eleanor L. Ormsby2 , Shervin Aminpour3 , Lydia P. Howell4
  • 1Department of Radiology, Neuroradiology Section, Universidad de Antioquia, Medellin, Colombia
  • 2Department of Radiology, Neuroradiology Section, Universidad de Antioquia, Medellin, Colombia
  • 3Department of Otolaryngology, Universidad de Antioquia, Medellin, Colombia
  • 4Department of Pathology and Laboratory Medicine, UC Davis Medical Center, Sacramento, CA
Further Information

Publication History

Publication Date:
29 October 2008 (online)

ABSTRACT

Background and objectives: The purpose of this study was to describe common radiographic patterns that may be useful in predicting the diagnosis of rhinocerebral mucormycosis. Methods: We retrospectively evaluated the imaging and clinical data of four males and one female, 3 to 72 years old, with rhinocerebral mucormycosis. Results: All the patients presented with sinusitis and ophthalmological symptoms. Most of the patients (80%) had isointense lesions relative to brain in T1-weighted images. The signal intensity in T2-weighted images was more variable, with only one (20%) patient showing hyperintensity. A pattern of anatomic involvement affecting the nasal cavity, maxillary sinus, orbit, and ethmoid cells was consistently observed in all five patients (100%). Our series demonstrated a mortality rate of 60%. Conclusion: Progressive and rapid involvement of the cavernous sinus, vascular structures and intracranial contents is the usual evolution of rhinocerebral mucormycosis. In the context of immunosupression, a pattern of nasal cavity, maxillary sinus, ethmoid cells, and orbit inflammatory lesions should prompt the diagnosis of mucormycosis. Multiplanar magnetic resonance imaging shows anatomic involvement, helping in surgery planning. However, the prognosis is grave despite radical surgery and antifungals.

REFERENCES

  • 1 Rumboldt Z, Castillo M. Indolent intracranial mucormycosis: case report.  AJNR Am J Neuroradiol. 2002;  23 932-934
  • 2 Chan L L, Singh S, Jones D et al.. Imaging of mucormycosis skull base osteomyelitis.  AJNR Am J Neuroradiol. 2000;  21 828-831
  • 3 Anselmo-Lima W T, Lopes R P, Valera F C et al.. Invasive fungal rhinosinusitis in immunocompromised patients.  Rhinology. 2004;  42 141-144
  • 4 Paulltauf A. Mycosis mucorina.  Virchows Arch. 1885;  102 543
  • 5 Naussbaum E S, Holl W A. Rhinocerebral mucormycosis: changing patterns of disease.  Surg Neurol. 1994;  41 152-156
  • 6 Hopkins M A, Treloar D M. Mucormycosis in diabetes.  Am J Crit Care. 1997;  6 363-367
  • 7 Kohn R, Helper R. Management of limited rhino-orbital mucormycosis without exenteration.  Ophthalmology. 1985;  92 1440-1443
  • 8 Abramson E, Wilson D, Arky R A. Rhinocerbral phycomycosis in association with diabetic ketoacidosis.  Ann Intern Med. 1967;  66 735-742
  • 9 Rangel-Guerra R A, Martinez H R, Saenz C et al.. Rhinocerebral and systemic mucormycosis: clinical experience with 36 cases.  J Neurol Sci. 1996;  143 19-30
  • 10 Thajeb P, Thajeb T, Dai D. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy.  Scand J Infect Dis. 2004;  36 643-648
  • 11 Ochi J W, Harris J P, Feldman J I et al.. Rhinocerebral mucormycosis: results of aggressive surgical debridement and amphotericin B.  Laryngoscope. 1988;  98 1339-1342
  • 12 Sheman D D. Orbital Anatomy and Its Clinical Applications. Philadelphia, PA; Lippincott-Raven 1992: 1-26
  • 13 Gamba J L, Woodruff W W, Djang W T et al.. Craniofacial mucormycosis: assessment with CT.  Radiology. 1986;  160 207-212
  • 14 Terk M R, Underwood D J, Zee C et al.. MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation.  Magn Reson Imaging. 1992;  10 81-87
  • 15 Harril W C, Stewart M G, Lee A G et al.. Chronic rhinocerebral mucormycosis.  Laryngoscope. 1996;  106 1292-1297
  • 16 Van Johnson E, Kline L B, Julian B A et al.. Bilateral cavernous sinus thrombosis due to mucormycosis.  Arch Ophthalmol. 1988;  106 1089-1092
  • 17 Mohindra S, Mohindra S, Gupta R et al.. Rhinocerebral mucormycosis: the disease spectrum in 27 patients.  Mycoses. 2007;  50 290-296
  • 18 Mnif N, Hmaied E, Oueslati S et al.. Imaging of rhinocerebral mucormycosis.  J Radiol. 2005;  86 1017-1020
  • 19 Naussbaum E S, Holl W A. Rhinocerebral mucormycosis: changing patterns of disease.  Surg Neurol. 1994;  41 152-156
  • 20 Yohai R A, Bullock J D, Aziz A A et al.. Survival factors in rhino-orbital-cerebral mucormycosis.  Surv Ophthalmol. 1994;  39 3-22
  • 21 Gwaltney Jr J M. Acute community-acquired sinusitis.  Clin Infect Dis. 1996;  23 1209-1255

Diego A HerreraM.D. 

Neuroradiologist, Department of Radiology, Neuroradiology Section

Universidad de Antioquia, Medellin, Colombia

Email: herrera.diego@gmail.com

    >